Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics.
Daniel R. WongJay ConradNoah R. JohnsonJacob AyersAnnelies LaeremansJoanne C. LeeJisoo LeeStanley B. PrusinerSourav BandyopadhyayAtul J. ButteNick A. ParasMichael J. KeiserPublished in: Nat. Mach. Intell. (2022)